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Abstract: Background: The incidence of Alzheimer disease (AD) is increasing with the ageing population.
The development of low cost non-invasive diagnostic aids for AD is a research priority. This pilot study
investigated whether an approach based on a novel dynamic quantitative parametric EEG method could
detect abnormalities in people with AD. Methods: 20 patients with probable AD, 20 matched healthy
controls (HC) and 4 patients with probable fronto temporal dementia (FTD) were included. All had detailed
neuropsychology along with structural, resting state fMRI and EEG. EEG data were analyzed using the
Error Reduction Ratio-causality (ERR-causality) test that can capture both linear and nonlinear interactions
between different EEG recording areas. The 95% confidence intervals of EEG levels of bi-centroparietal
synchronization were estimated for eyes open (EO) and eyes closed (EC) states. Results: In the EC state,
AD patients and HC had very similar levels of bi-centro parietal synchronization; but in the EO resting
state, patients with AD had significantly higher levels of synchronization (AD = 0.44; interquartile range
(IQR) 0.41 vs. HC = 0.15; IQR 0.17, p < 0.0001). The EO/EC synchronization ratio, a measure of the dynamic
changes between the two states, also showed significant differences between these two groups (AD ratio
0.78 versus HC ratio 0.37 p < 0.0001). EO synchronization was also significantly different between AD
and FTD (FTD = 0.075; IQR 0.03, p < 0.0001). However, the EO/EC ratio was not informative in the FTD
group due to very low levels of synchronization in both states (EO and EC). Conclusion: In this pilot work,
resting state quantitative EEG shows significant differences between healthy controls and patients with AD.
This approach has the potential to develop into a useful non-invasive and economical diagnostic aid in AD.
Keywords: Alzheimer’s disease; electroencephalography; clinical marker; ROC curve; nonlinear dynamics
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1. Introduction
There is an urgent need for widely available low-cost diagnostic aids to detect cognitive
impairment and early signs of Alzheimer’s disease (AD) [1]. The electroencephalogram (EEG) has
been used clinically for many decades as a tool to help diagnose AD and other types of dementia.
EEGs are economical, non-invasive and have no-contraindications. EEG studies have consistently
shown abnormalities in AD patients; slowing of the posterior dominant rhythms and an increase in the
slow wave activity is the most common feature on visual inspection of EEGs of patients with AD [2].
Spectral EEG analyses provide the means for a more objective estimation of the frequencies involved
and for determining, to an extent, the spatial distribution of the abnormalities. Early changes in AD
are an increase in theta and a decrease in beta activity [2]; these EEG abnormalities are also associated
with cognitive deficits [2,3].
Advances in quantitative analysis from EEG recording (QEEG) have made it possible to
detect changes in synchronization between different brain regions, reflecting underlying network
dysfunction resulting from neuronal or synaptic death and loss of cholinergic inputs in this disease [2].
The characterization of EEG network alterations, therefore, holds promise to detect changes in people
with AD [2,4,5]. QEEG studies report decreases in synchronization estimated with measures of
coherence, between both contiguous and distant EEG channels in people with AD, suggesting
functional disconnection among cortical regions [2,6–8]. Stam et al. [9] used a technique called
synchronization likelihood, documenting decreased levels [10,11] as well as diminished fluctuations
in synchronization [12]. This reduction especially affected alpha and beta bands, although gamma
band decrease has also been reported [13]. The decrease in synchronization between brain areas may
not be due to loss of cortical neurons, as not all frequencies are equally affected [2,10], and increased
synchronization can also be found for slow rhythms [10]. Impairments in brain network function,
as detected using QEEG (and other techniques), may be one of the earliest features of AD [14]; therefore,
it can be a useful diagnostic aid as there is a need to detect AD as early as possible if clinicians are to
intervene and test new treatments.
Normal cognitive function requires the integrity of functional network dynamics [4,15,16],
and the study of oscillatory synchronization between different brain areas can provide information
on functional network activity [4]. The study of brain synchronization utilizes a number of different
techniques, such as measures of coherence (e.g., [17]). QEEG analysis of local and global networks
(i.e., hubs and modules—used to define aspects of healthy brain functioning [5]) has detected disruption
of brain networks in people with AD [5,11,18–20]. Networks that connect the parietal lobes appear to
be particularly affected [21,22]. Hata et al. used 40 s epochs of EEG, recorded from people with AD,
and found decreased lagged phase synchronization between the right dorsolateral prefrontal cortex
and the right posterior-inferior parietal lobule within the theta band [22].
QEEG can also measure complexity of signal as well as brain synchronization or connectivity.
Non-linearity is a necessary condition of the highly-complex nature of brain function. QEEG can be
quantified with several nonlinear methodologies that may be advantageous in detecting brain network
dysfunction. Abasolo et al. [23] used the SampEn nonlinear method and demonstrated significantly
lower levels of complexity in the occipital and parietal lobes of patients with AD. Electrode O1 had
the highest sensitivity (90.9%; ROC score = 89.3%) and P3 the highest specificity (90.9%; ROC score
= 85.1%), producing a combined accuracy of 81.8% [23,24]. Abasolo also used another nonlinear
methodology, the Lempel-Ziv complexity that further demonstrated significantly-lower complexity
scores in AD patients [23]. The authors inferred that people with AD have more regular and less
complex activity in posterior (parietal and occipital) brain regions. Their approach is based on single
recording positions and does not provide information on the underlying functional connectivity
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between areas. Other authors have also demonstrated reduced brain complexity as measured using
nonlinear methods in people with AD [2,25–27].
Despite evidence of altered brain synchronization and network dysfunction in people with AD,
it is not clear which EEG states are most useful to sample: epochs of Eyes-Open (EO), Eyes-Closed (EC),
or mixed EO-EC. Moreover, this procedural detail is often not reported in published studies. The evidence
that patients with AD show loss of brain responsiveness to environmental stimuli [2,28] suggests that
dynamic changes between EO and EC might represent an ideal paradigm to investigate the effect of AD
pathophysiology. For example, Miraglia et al. [29] used graph theory analysis of EO versus EC QEEG to
reveal changes of EEG reactivity.
We have developed a novel QEEG parametric data analysis technique—the Error Reduction
Ratio-causality (ERR-causality) test [30]—that can measure levels of synchronization with high
temporal resolution. The ERR-causality test makes no assumptions about the type of EEG interactions
and is able to detect both linear and nonlinear synchronization. This analytic technique has been
compared to other QEEG measures from sleep recordings and in patients with epilepsy ([30] and
Appendix A), with favourable results.
In this pilot study, the ERR-causality method was applied to EEG recordings acquired in a cohort
of patients with Alzheimer’s disease in the early dementia phase and healthy controls (HC) in order to
measure linear and non-linear synchronization between the two hemispheres. We decided to select
parietal lobe regions and focused on bi-hemispheric synchronization because there is a large body
of available supporting evidence that reports early dysfunction or pathology in these areas in AD.
Evidence includes findings from studies of brain metabolism [31], task fMRI activation [32], resting
state fMRI [33,34] and QEEG studies of brain connectivity [5,11,18–24,35]. Furthermore, parietal
areas are relatively spared by artifacts triggered by eye-blinking and/or temporal muscle contraction.
As patients with AD show loss of brain responsiveness to environmental stimuli [2,28], both EC
and EO states were acquired and analyzed. We also included a small group of patients with fronto
temporal dementia (FTD) to rule out non specific effects of neurodegeneration. We hypothesized that
estimates of EEG synchronization with the ERR test between the homologous centroparietal areas
during EO and EC states would allow differentiation between patients with AD and healthy controls.
We demonstrate in this pilot study that this novel approach reveals alterations in brain bi-hemispheric
synchronization, and has the potential to become a useful diagnostic aid in people with cognitive
impairment related to AD.
2. Materials and Methods
2.1. Study Design
All EEG data were acquired and analyzed prospectively. A task-free EEG that requires minimal
cooperation was chosen as AD patients may have difficulty engaging with and following cognitive
tasks. The parametric ERR-causality technique is a very dynamic method (resolution of 0.5 ms at
a sampling rate of 2 KHz) that works very well on small, few-second epochs of EEG data without any
assumptions regarding linear or nonlinear dynamic relationships between two time series. The data
were not segmented into frequency bins because in nonlinear dynamic systems that can exhibit
harmonics and inter-modulation effects. It is likely that exciting frequencies can be transferred by the
nonlinear effects to other frequency locations and can, therefore, move energy between bins, that would
consequently corrupt any subsequent analysis. In this study, synchronization estimates were produced
between homologous centroparietal (and frontal for comparison) EEG areas. Other EEG electrode
combinations were not analyzed.
2.2. Sample
All participants were recruited from Sheffield Teaching Hospitals NHS Foundation Trust memory
clinics, and HC were enrolled through opportunistic sampling and word of mouth. The Sheffield
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Teaching Hospital memory clinic is a young-onset memory clinic, seeing people predominantly aged
under 65. The study recruited participants from September 2014 to March 2017. The patient sample
included 20 participants with a clinical diagnosis of AD and four with a clinical diagnosis of FTD.
The participants with AD had been diagnosed 1 month to 2 years prior to this study and were in the
mild to moderate stages of disease, with a mean Mini Mental State Examination (MMSE) score of
20.10 (standard deviation 4.00). The diagnosis of AD was based on the NINCDS-ADRDA criteria [36];
participants with FTD were diagnosed according to the Rascovsky criteria [37]. Diagnosis was reached
based on a consensus of multidisciplinary evidence, taking into account clinical history, neurological
examination, neuropsychological scores, and neuro-radiological findings.
Nine out of the 20 patients with AD were scanned with technetium-99-hexamethylpropylene
amine oxime (HMPAO) SPECT imaging that revealed parietal and temporal lobe hypoperfusion
consistent with AD. All participants with AD were on standard treatment—17 were taking
acetylcholinesterase inhibitor medication (AChEI; 13 taking Donepezil, one Galantamine and one
taking Rivastigmine) and three were taking Memantine; two received memantine because they did
not tolerate initial treatment with an AChEI and one for cardiac contraindication that precluded
using an AChEI). All EEGs were performed while patients were taking medication at a stable dose.
Six patients were also on anti-depressants, with one additionally receiving an anti-epileptic medication
for myoclonus (levetiracetam). One further participant (not on anti-depressants) received anti-epileptic
medication for seizures (lamotrigine). No participants were taking benzodiazepines. None of the
patients with FTD were on any psychoactive medication.
Data were also collected from a sample of 20 age and gender matched healthy controls. Everyone
underwent an extensive battery of neuropsychology testing, and structural and functional MRI imaging
(see below).
2.3. Magnetic Resonance Imaging Acquisition
All patients were scanned with high-resolution structural MRI to rule out major etiologies that
could otherwise account for their clinical symptoms. No patient had significant small vessel ischemic
disease, as supported by a fluid-attenuated inversion recovery (FLAIR) MRI scan acquisition.
Each participant consented to undergo a 3 T (Philips Ingenia) MRI scanning protocol,
which included structural images and resting-state functional scans. Additional diffusion, T2 weighted
and FLAIR acquisitions served to verify/corroborate the absence of exclusion criteria. MRI assessments
were obtained up to an average of 79 days prior to study inclusion. Structural and functional
neuroimaging served for the sole purpose of characterizing brain structure and brain function in the
group of patients, to ensure that they were typical of the clinical population object of this investigation.
Anatomical T1-weighted volumes were acquired tri-dimensionally with the following
parameters—voxel dimension: 0.94 × 0.94 × 1.00 mm, field of view: 256 mm, matrix size:
256 × 256 × 124, repetition time = 8.2 s, echo delay time 3.8 ms, flip angle: 8◦. Following a series
of dummy scans set up to allow electromagnetic equilibrium, a T2*-weighted scan was recorded to
measure cerebral hemodynamics at rest. This scan included 120 volumes, each of which consisted
of 35 axial slices, contiguously acquired in ascending order. Participants were invited to close their
eyes for the whole duration of the scan. The following specifics were set up—repetition time = 2.6 s,
total acquisition time: 4 m and 30 s, echo delay time = 35 ms, flip angle: 90◦, voxel dimensions:
2.4 × 2.4 × 4.0 mm, field of view: 230 × 230 × 140 mm.
2.4. Magnetic Resonance Imaging Analysis
All MRI images were preprocessed and modelled with SPM12b software (Wellcome Centre for
Human Neuroimaging, London, UK), implemented in a Matlab environment (vR2011b, The Mathworks,
Natick, MA, USA).
Following voxel-brain-morphometry procedures [38], T1-weighted images were initially segmented
to separate gray matter (GM) and white matter (WM) from non-neural tissue classes. GM maps
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were then registered to the Montreal Neurological Institute space, and were smoothed with an 8 mm3
full-width at half maximum Gaussian kernel. Furthermore, unprocessed images were elaborated with
the fully-automatized “STEPS” procedure (available online at http://cmictig.cs.ucl.ac.uk/niftyweb/),
which, thanks to the optimized use of multiple templates, enables an accurate segmentation of the left and
right hippocampus [39]. All native-space output sub-maps were processed with the “get_totals” script
(www.cs.ucl.ac.uk/staff/g.ridgway/vbm/get_totals.m) for the calculation of absolute and fractional
volumes of the hippocampus and global maps of GM and WM. Absolute volumes were expressed
in milliliters. Fractional volumes were obtained by dividing each tissue-class volume by the total
intracranial volume (TIV), which was computed, in turn, by adding up global volumes of GM, WM,
and cerebrospinal fluid.
A standard pipeline was chosen to preprocess resting-state functional scans. Volumes were
initially slice-timed and realigned. The graphical output of realignment was visually inspected to
ascertain that no participant showed excessive in-scanner motion. Realigned runs were then spatially
normalized using the default echoplanar SPM template, and voxel size was rendered isotropic at
2.0 × 2.0 × 2.0 mm. After normalization, volumes were band-pass filtered (0.01 Hz–0.1 Hz) to
eliminate frequencies not believed to be of neurogenic origin. For this purpose, the REST toolbox
(www.restfmri.net) was used [40]. Images were finally smoothed with a 6 mm3 full-width at half
maximum Gaussian kernel.
For a characterization of default-mode network (DMN) hemodynamic circuitry, brain networks
were computed with a group-level independent component analysis [41], using the GIFT toolbox
(v1.3i, mialab.mrn.org/software/gift). Independent component analysis separates latent sources
of variability based on the matrix of correlations among the measured variables (the time-course
recorded in each voxel). The Infomax algorithm was chosen in order to minimize mutual information
of components, and the number of components to estimate was set at 20. The results were
visually inspected and, upon agreement between two independent raters (MDM and AV), the DMN
was selected among the 20 components based on its map, which normally includes the posterior
cingulate, the medio-prefrontal region, the inferior parietal lobule, the lateral temporal cortex and the
hippocampal formation [42].
2.5. EEG Recordings
EEG recordings were acquired with a modified 10/10 overlapping a 10/20 international system
of electrode placement method. All recordings were made with an XLTEK 128-channel headbox
(Optima Medical LTD, Surrey, UK) at a sampling rate of 2000 Hz (analogue bandwidth 0.15–680 Hz)
with scalp Ag/AgCL electrodes. A linked earlobe reference was used for all participants (jump cables
were used to combine both electrodes into one input; care was taken for impedance to be equal on
both sides). A 30-min resting state EEG recording was obtained, including alternating 5-min EO and
EC epochs (during which the participants were encouraged not to think about anything specific).
Thirty minutes is longer that the analysis requires, but allows representative epochs to be selected.
If participants showed signs of drowsiness, they were prompted.
An experienced neurophysiologist reviewed all EEGs on the XLTEK review station with
time-locked video recordings (Optima Medical LTD) with a bipolar montage that included the
following channels: Fp2-F8, Fp1-F7, F8-F4, F7-F3, F4-C4, F3-C3, F4-FZ, FZ-CZ, F3-FZ, T4-C4, T3-C3,
C4-CZ, C3-CZ, CZ-PZ, C4-P4, C3-P3, T4-T6, T3-T5, P4-PZ, P3-PZ, T6-O2, T5-O1, P4-O2, P3-O1 and
O2-O1. Two 12-s artefact free epochs (one EO and one EC) were selected. For consistency, the first
12-s epoch for each patient for EO and EC was used for further analysis. Data were exported in
Spike 2 (version 8) software and all the aforementioned EEG bipolar derivations were produced and
then processed with a time constant of 0.08 (high pass filter at 2 Hz), to attenuate any remaining low
frequency artifacts like those generated by eye blinking and slow movements.
The ERR-causality synchronization estimates were produced using an in-house software
developed by a complex-signal analysis engineering team. Briefly, the ERR is an extension of the
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Granger causality test and incorporates a model to characterize the causal interaction over time
between two signals, denoted by X and Y. At a specific time, the following possibilities can occur:
signal X causes Y, Y causes X, X and Y are coincident, or there is no interaction, or bidirectional
interactions occur between them. Both X and Y may have been caused by an input u, but here u
is unknown and not measurable. Steps involve: construct a candidate term set which is typically
constructed by past information of Y, for example y(t − 1),y(t − 12), . . . and past information of X,
for example x(t − 11), x(t − 12), ... with a specific model order d. Apply the adaptive-forward-OLS
algorithm which has been derived from the orthogonal least squares (OLS) algorithm [43] and compute
ERR and the penalized error-to-signal ratio PESR) [44] value for each candidate term. ERR indicates
how much of the variance change in the system response is caused by the considered term, expressed
as percentage. If the significant terms selected by this algorithm based on values of ERR include
any term from the past information of X, this indicates that signal X leads Y during the considered
time duration (t − 1h/2, t + h/2), where h denotes the sampling window size. This was selected at
1000 data points (corresponding to 0.5 s) for this study. The ERR-causality from X to Y at time t,
expressed as Fx > y(t) is then defined as 1. If no component from the past information of X is included
in the selected significant terms, this indicates that X has no interaction with Y during [t − h/2, t + h/2]
and Fx > y(t) is defined to be 0. The strength of Fx > y(t) can be estimated using the summed ERR
values of all the selected terms from past information of X, the maximum strength being 1. The time
shift of X > Y is defined as the time lag of X in the first term ranked by the values of ERR. For a complex
system, the causality is often time varying and the interactions are often dynamic and nonlinear.
Linear and nonlinear interactions can be separated and analyzed independently with this method,
which is relevant as the nonlinear dimension appears to be important in the pathophysiology of AD
and cannot be assessed by conventional QEEG methods [2,25]. Further details of the ERR methodology
are included in Appendix A.
One EO and one EC 12-s epochs were selected for each subject to produce the 95% confidence
intervals for EO and EC synchronization levels. The 95% confidence interval is used to measure
synchronization variability. The 95% confidence interval is represented by µ ± 1.96σ, where µ and σ
denote the mean and standard deviation of the samples, respectively. This was carried out on a 6-s
period internal to the epoch, in order to enable visual assessment of the 95% confidence interval for the
remaining 6 s for each case, both for EO and EC states (Figure 1).
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Figure 1. This figure illustrates the results of our novel QEEG method, the EER-causality test. The figure
includes screen shots taken from the software results screen. The data included are from one participant
with AD on the left and a HC on the right. The top half of the panel is from the eyes open (EO) state
and lower panel from eyes closed (EC) state. Each EC and EO resting state contains 12 s EEG epochs.
For each EO and EC state, AD (left) and HC (right), row one shows the normalized EEG data from
the homologous centroparietal areas, row two the time lag estimates (not used in our current work),
row three the strength of synchronization (causality: degree of association between the centroparietal
EEG time series), and row four the 95% confidence intervals for the strength of synchronization.
The color-coding indicates the direction of synchronization; blue = right drives left, red = left drives
right, green = isochronous zero-lag synchronization. Please note that in the EO state, there are dynamic
fluctuations in the level of synchronization with peaks of causality exceeding 0.5 in the AD participant,
not seen in the HC example. These fluctuating bursts of high-level synchronization are captured with
our dynamic methodology and they are best expressed in the 95% confidence intervals of the strength
of synchronization.
We analyzed bifrontal synchronization using the F8-F4 and F7-F3 derivations as a control area,
as this region is less commonly affected in AD. The ratios of EO versus EC synchronization were
calculated for all participants with the ERR-causality test. Although the investigators in charge of
carrying out the ERR-causality method were aware of the clinical diagnosis during data analysis,
selection bias was avoided by consistently choosing the first, in chronological order, EO and EC epoch
from each EEG recording.
2.6. Neuropsychological Assessment
The cognitive profile of AD patients and healthy controls was determined using an extensive battery
of neuropsychological tests, specifically devised to be sensitive to cognitive difficulties typically triggered
by AD [45]. This included the Mini Mental State Examination [46], tests of short and long-term memory
(verbal and non-verbal) [47] tests of abstract reasoning [47,48] tests of attention and executive function [49],
language comprehension, naming by confrontation, category and letter fluency [50] (a specific focus on
the cognitive domains most relevant for the purpose of this investigation is given below in Table 1).
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Table 1. Demographic data, Structural MRI & Neuropsychology results.
Variable AD Patients Healthy Controls p
Demographics
Age at MRI scan (years) 63.95 (8.34) 67.35 (11.79) 0.429
Education (years) 11.75 (2.05) 15.20 (2.98) <0.001
Gender (f/m) 10/10 11/9 0.752
Mini Mental State Examination (max. 30) 20.10 (4.00) 28.20 (1.36) <0.001
Brain Structure-Absolute Volumes
Left Hippocampus (mL) 2.08 (0.48) 2.59 (0.24) <0.001
Right Hippocampus (mL) 2.21 (0.48) 2.61 (0.34) 0.007
Grey Matter (mL) 550.24 (83.00) 627.19 (61.11) 0.003
White Matter (mL) 396.76 (58.17) 418.40 (39.01) 0.192
Brain Structure-Fractional Volumes
Grey Matter 0.38 (0.05) 0.43 (0.05) 0.002
White Matter 0.28 (0.04) 0.29 (0.02) 0.121
Cognition
Letter Fluency Test * 20.79 (13.77) 48.40 (14.21) <0.001
Category Fluency Test * 22.00 (9.90) 56.80 (13.56) <0.001
Prose Memory Test-Immediate Recall (max. 24) * 4.37 (3.62) 15.15 (3.53) <0.001
Prose Memory Test-Delayed Recall (max. 24) * 4.42 (4.31) 19.65 (2.28) <0.001
Stroop Test-Time Interference * 29.61 (21.09) 13.70 (4.20) 0.016
Stroop Test-Error Interference * 12.22 (10.59) 0.00 (0.00) <0.001
Visuoconstructional Praxis Test (max. 14) 7.55 (3.94) 12.35 (1.53) <0.001
Means and standard deviations are indicated. Mann-Whitney U test between groups were run for each comparison.
A Chi-Square test was used for gender. One AD patient did not complete the tests marked by an asterisk.
2.7. Statistical Methods
Summary statistics were calculated for each of the outcomes, split by group. Demographic
data, global indices of absolute and fractional brain anatomy, and neuropsychology results were
tested for selection bias (Wilcoxon Mann-Whitney test). Moreover, to ensure that AD patients did
not move away from well-established patterns of disease effects, comparisons were run to model
between-group differences in regional maps of GM and in maps of DMN connectivity (two-sample
t tests). A cluster-level p value (corrected for Family-Wise Error) < 0.05 was set as threshold of
significance. The nonlinear transform available at “http://imaging.mrc-cbu.cam.ac.uk/downloads/
MNI2tal/mni2tal-m” was used to transpose Montreal National Institute peak coordinates into the
Talairach Space. The Talairach Daemon Client [51], finally, served for interpretational purposes.
The QEEG results were tested for differences between the HC, AD and FTD groups using the
Wilcoxon Mann-Whitney test for two independent samples. ROC curves were constructed using data
from AD and HC groups, showing sensitivity and specificity for our proposed diagnostic tool.
This study was approved by the Yorkshire and The Humber (Leeds West) Research Ethics
Committee (reference number 14/YH/1070). All participants gave their informed written consent.
3. Results
The demographic data, MRI and neuropsychology results are summarized in Table 1. This shows
that HC and AD were both age and gender matched, but the HC did have a higher level of education.
In support of a diagnosis of AD, all participants, including all HC, had detailed neuropsychology
(Table 1), with AD subjects showing profiles consistent with AD and normal profiles in healthy controls.
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3.1. MRI Results
Structural and functional MRI analyses revealed patterns of atrophy and dysfunction as expected
in AD, suggesting that the sample selected for this study was typical of the AD population of mild
to moderate severity. In detail, significantly smaller mean gray matter volume was detected in the
group of AD patients (Table 1). Voxel-based morphometry analysis showed decreased gray-matter
volumes in patients in a series of neocortical regions, including the parietal, prefrontal, and temporal
lobes. Moreover, bilateral volumetric decrease was found in the hippocampus and overall in the
mediotemporal complex (Figure 2A). Analysis of resting state fMRI showed that patients with AD
had significantly reduced DMN connectivity in a cluster located in the posterior cingulate/precuneus,
when compared to controls (Figure 2B)
Figure 2. (A) Structural MRI, group comparison between AD and HC; Structural MRI comparison
between the two diagnostic groups showing the regions where HC had larger grey-matter volumes
than AD patients. Results show clusters surviving a Family-Wise-Error corrected cluster-level p < 0.05.
Montreal Neurological Institute coordinates are indicated at the bottom of each slice. (B) Functional
MRI, group comparison between AD and HC. fMRI comparison between AD and HC groups showing
the regions where HC had more DMN fMRI connectivity than AD patients. Differences were visible
in a cluster surviving a Family-Wise Error corrected cluster-level p < 0.05 extending to the posterior
cingulate gyrus and precuneus (peaks in Brodmann Areas 7, 29 and 31). Montreal Neurological Institute
coordinates are indicated in the figure. This finding is consistent with previous publications and shows
loss of connectivity in the posterior part of the DMN.
3.2. QEEG Results
The QEEG results were not normally distributed. Hence, non-parametric tests were used to
compare the two groups. QEEG measurements of EC bi-centroparietal synchronization showed no
significant difference between participants with AD and HC. However, patients with AD had higher
levels of median synchronization during EO (AD 0.44 vs. HC 0.15, p < 0.0001), Table 2 and Figure 3.
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Table 2. QEEG results-ERR-causality test.
EEG Index AD Median(IQR)
FTD Median
(IQR)
HC Median
(IQR) AD vs. HC AD vs. FTD HC vs. FTD
Bi-centroparietal (C3–P3 to C4–P4)
Eyes closed 95% CI
top level 0.53 (0.071) 0.14 (0.27) 0.485 (0.53) p = 0.968 p = 0.037 p = 0.018
Eyes open 95% CI
top level 0.435 (0.41) 0.075 (0.03) 0.15 (0.17) p < 0.0001 p < 0.0001 p = 0.018
EO/EC ratio 0.784 (0.386) 0.586 (0.386) 0.371 (0.346) p < 0.0001 p = 0.241 p = 0.575
Bi frontal (F3–F7 to F4–F8)
Eyes closed 95% CI
top level 0.185 (0.27) 0.07 (0.04) 0.11 (0.11) p = 0.149 p = 0.018 p = 0.081
Eyes open 95% CI
top level 0.09 (0.1) 0.08 (0.04) 0.09 (0.08) p = 0.64 p = 0.431 p = 0.431
EO: Eyes-open; EC: eyes-closed; CI: Confidence interval; IQR: Interquartile range (distance between the 5th percentile
and the 95th percentile). Median and interquartile ranges are shown, as the data was not normally distributed.
EO/EC Bi-frontal synchronization not shown.
Figure 3. QEEG bi-centroparietal synchronization, group comparison between AD, HC & FTD.
This graph depicts the median with 95% CI bi-centroparietal (C3–P3 to C4–P4) synchronization for
Eyes Closed (EC) and Eyes Open (EO) states from HC-Healthy Controls (n = 20) and AD-Alzheimer’s
disease (n = 20) & FTD–frontotemporal dementia (n = 4). The non-parametric Mann Whitney test of
group differences was used.
Interestingly, the ratio of EO versus EC synchronization, a measure of dynamic changes between
two states, shows a significant difference between AD and HC (AD 0.78 vs. HC 0.37, p < 0.0001, Table 2
and Figure 4). An EO/EC bi-centroparietal ratio of 0.51 produces sensitivity and specificity of 95% and
75%, respectively. Even after correcting for education levels, these results retained their significance.
The age range of our HC cohort was between 48–86 years, with 10 participants above the age of 70.
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Figure 4. QEEG EO/EC bi-centroparietal synchronization ratio, group comparison between AD and
HC (including ROC). This figure depicts the EO/EC bi-centroparietal synchronization ratios for HC
(Healthy Controls) and AD (Alzheimer disease). The ROC curve represents a cut-off point at 0.51 for
all participants producing a sensitivity of 95% and specificity of 75%.
EO versus EC synchronization was also tested for comparison between homologous frontal
lobes as these are relatively spared in AD. We estimated synchronization between F8–F4 & F7–F3.
This showed no significant difference in either state (EO or EC) between AD and HC. There was also
no dynamic change observed between the EO and EC states for HC and AD (see Table 2 and Figure 5).
The patterns of bi-centroparietal synchronization seen in patients with FTD differ from those
seen in patients with AD. Specifically, participants with FTD have much lower EO bi-centroparietal
synchronization when compared to the AD groups (0.08 vs. 0.44, p < 0.001) (see Table 2). The FTD
cohort also had significantly lower levels of EO bi-centroparietal synchronization compared to healthy
controls (0.08 vs. 0.15 p = 0.018 and EC state 0.14 (IQR 0.27) vs. 0.484 (IQR 0.53), p = 0.018, see Table 2).
The EO/EC bi-centroparietal synchronization ratio appears to be not informative in the FTD group
because minimal levels of synchronization were measured from both EO and EC states.
Figure 5. QEEG bi-frontal synchronization, group comparison between AD & HC. This graph depicts
the median with 95% CI bi-frontal (F3–F7 to F4–F8) synchronization for Eyes Closed (EC) and Eyes
Open (EO) states from three groups; HC-Healthy Controls (n = 20), AD—Alzheimer’s disease (n = 20),
FTD—Fronto-Temporal Dementia (n = 4). The graph shows no significant differences in the degree of
synchronization measurements for each group and, additionally, for each state (i.e., EO & EC), there is
no difference within each group.
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Finally, electro-clinical correlations were explored by assessing the relationship between EO/EC
bi-centroparietal synchronization ratio for each participant against a series of factors, including age,
MMSE, and the cognitive tests most frequently used in clinical settings to aid a diagnosis of AD
(Figure 6 and Table 2). For this purpose, a non-parametric coefficient of correlation (Spearman’s rank
correlation coefficient, rho) was chosen and a p < 0.01 was used. Age was not correlated with EO/EC
ratio (rho = −0.074, p > 0.01). The association between EO/EC bi-centroparietal synchronization
ratio and the MMSE score was highly significant (rho = −0.606, p < 0.001). Significant correlations
were also found between the EO/EC bi-centroparietal synchronization ratio and test performance in
various cognitive domains (see Figure 6): memory (Prose Memory Test-Immediate Recall: rho = −0.537,
p < 0.001; Prose Memory Test-Delayed Recall: rho = −0.489, p = 0.002), semantic processing (Palm Trees
Test: rho = −0.616, p = 0.004; Category Fluency Test: rho = −0.767435, p < = 0.001, visuospatial abilities
(Visuoconstructional Praxis Test: rho = −0.704448, p < = 0.001004), and language comprehension
(Token Test: rho = −0.875, p < 0.001). However, the bi-centroparietal synchronization ratio did not
correlate with executive functioning (Stroop Test-Time Interference: rho = 0.134, p = 0.429; Letter
Fluency Test: rho = −0.229, p = 0.162) that predominantly relies on frontal lobe function. This shows
concordance between location of cognitive function testing and our electrophysiological measure.
Figure 6. Electroclinical (neuropsychology) correlations. Relationship between EO/EC bi-centroparietal
synchronization ratio and a series of variables, including age, general cognitive level, verbal episodic
memory, visuoconstructive abilities, and verbal fluency. Although these analyses were carried out using
non-parametric rank-based correlations (see Results section), a linear model was fitted for the sole purpose
of visualization. The r correlations (perfectly mirroring nonparametric statistics) are as follows—Age:
r = −0.116, p = 0.475; MMSE: r = −0.629, p < 0.001; long-term verbal memory: r = −0.508, p = 0.001;
visuoconstructive praxis: r = −0.537, p < 0.001; category fluency: r = −0.338, p = 0.035; letter fluency:
r = −0.205, p = 0.211.
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4. Discussion
The results from this small pilot study are encouraging and show a significant difference in
EO bi-centroparietal synchronization between people with mild to moderate Alzheimer’s disease
and healthy controls. The relative young age of our AD cohort (mean age of 63.95) reflects the
referral pattern to a young onset memory service (commonly patients younger than 65 are referred
to our clinic). To safeguard against any spurious demographic effect, the healthy control and AD
sample were age and gender matched in this study. All participants, including HC, underwent
a detailed neuropsychology assessment. It is reassuring that our electrophysiological measure
(EC/EO bi-centroparietal synchronization) correlated with cognitive scores. Further work is, however,
required to explore if this technique can detect cognitive impairment due to other causes.
This is the first time the ERR causality test has been used in the field of dementia. We have
previously shown that this test has significant advantages over other measures of synchronization,
such as coherence, due to its ability to detect linear as well as non-linear interactions [52]. In fact,
coherence provides a normalized average level of synchronization estimated over a fixed period
of time, which might reduce or even fail to reveal important dynamic changes and nonlinear
interactions. The advantages associated with the use of non-linear analyses in this field are widely
recognized [25–27], and very recently non-linear deficits on EEGs from patients with AD have been
shown to involve the centroparietal areas [53]. Additionally, our method only requires short periods of
EEG data.
The ERR-causality test procedure was carried out in both EO and EC states, in order to disentangle
possible group-differences in the dynamic shift between resting-state conditions. This concept is
not new and Pritchard and coworkers [26,28] have previously demonstrated something similar in
patients with AD. In their work, these authors used a non-linear estimate, called D2, a reflection
of the complexity of the cortical dynamics on EEG recordings, and revealed prominently increased
complexity during the EO, compared to the EC state in healthy controls, but no significant differences
between the two states in AD. The authors interpreted these data as a loss of brain responsivity to
changing environmental stimuli. Work from the same group has also highlighted the positive impact
on predictive classification of AD versus HC by implementing non-linear EEG measures [26].
This pilot study shows that using the ERR test, we can detect a large difference between AD
patients and HC when computing the EO/EC ratio of bi-centroparietal synchronization. HC are
able to desynchronize their EEGs by more than 50% during EO periods, whereas patients with AD
can do so only by an average of 20%. Stam and colleagues [12] showed an analogous finding with
reduced fluctuations on EEG synchronization in AD. These observations are of interest as there is
evidence that a balanced and temporally precise pattern of synchronization and desynchronization
is of paramount importance for normal cognitive function [15]. Our results suggest that estimates of
EEG synchronization are state dependent (Figure 3) and it is important for EO and EC epochs to be
analyzed separately.
EEG offers unique temporal resolution to assess functional brain network connectivity and,
as cognitive brain function occurs within the millisecond range, it has unique characteristics for the
development of a diagnostic tool for dementia [2,4]. The ERR-causality test has the advantage of
being a parametric technique that measures accurately levels of synchronization between pairs of EEG
electrodes, and can detect dynamic changes without making any assumptions about the stationarity of
the signals [30]. This test does not require fitting of a complete model to produce its estimates and as
a result it is fast and computationally not particularly demanding.
This pilot study has limitations. First, it was based on a small number of participants. However,
a large number of clinical measures were put into practice to characterize both patient and control groups
and to ensure that the AD patients were representative of the typical AD population of comparable
severity. All participants, including the control sample, underwent detailed neuropsychology and brain
imaging. Group analyses to assess cerebral atrophy and DMN connectivity revealed results consistent
with the literature, demonstrating extensive parietal, temporal, mediotemporal/limbic GM decrease and
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loss of DMN connectivity in the posterior cingulate/retrosplenial cortex. Second, the groups were not
well matched for education. This difference, however, does not represent a major issue, since it is well
established that low education levels are a risk factor for the onset of AD, and, overall, it is normal to
observe lower levels of education in AD patients than in healthy age-matched controls. Education was
only controlled for through post-hoc analyses. Third, six patients were taking types of medication that
can affect EEG signal; none of the patients were taking benzodiazepines that can cause an excess of fast
activity [54]. The AChEI medications that some of our patients were receiving during the EEG recordings
have been shown to reduce the amount of delta and theta activity, and increase the dominant alpha
rhythm [55]. A case study has looked at memantine (three of our patients were on treatment with this
medication) showing a reduction of pathological theta rhythms after several months [56]. Memantine is
more frequently used in people with more severe AD and hence this patient group may have had more
severe changes detectable on EEG. It is unlikely that any of the aforementioned medications could have
influenced the findings of this study, since only 30% of our patient group was on this type of medication.
However, further studies in the area of QEEG and response to anti-dementia medication are required.
Diagnostic criteria for AD include biological markers (such as cerebrospinal fluid and amyloid
PET imaging), but these are invasive or expensive, and neither is widely available. We did not have
these biomarkers available for this cohort, but have characterized them with structural and functional
MRI and detailed neuropsychology and regular follow-up over at least three years. The QEEG ERR test
used on resting state EEG recordings in this study is easy to use, non-invasive, economical to administer,
and potentially portable. We argue that this novel QEEG test has the potential to become a useful
diagnostic aid in the assessment of people with cognitive complaints [1]. It also has the potential
to produce an electrophysiological AD biomarker. Devising a biomarker is a long and complicated
process. Nonetheless, such a biomarker is urgently needed, both for the clinical management of AD,
as well as for the selection of patients for clinical trials of new therapies.
The findings of this pilot work are encouraging as the ERR causality test shows a strong
correlation between the EO/EC bi-centroparietal synchronization ratio and the neuropsychology
measures of episodic memory, semantic processing, and visuo-constructive abilities. Alteration in our
electrophysiological test does not correlate with age and hence it does not simply reflect age-related
brain changes. Previous studies using QEEG have shown good correlation with MMSE [57]. However,
these studies did not have detailed neuropsychology results on healthy volunteers, which is a strength
of our study.
Our major future objective is to assess the value of this test in the prodromal phase of the
disease (mild cognitive impairment due to AD, or presymptomatic AD according to Dubois proposed
criteria [58]). This may be challenging, as, at this stage, changes in synchronization and connectivity
are reported to be different than those observed in AD [13,59–61], most likely as a consequence
of either compensatory or maladaptive mechanisms [62]. Further studies will require longitudinal
data collection with detailed neuropsychology, clinical and radiological follow-ups. This study was
designed to assess if our QEEG method could distinguish a well-characterized group of participants
with dementia due to Alzheimer’s disease from healthy controls.
In summary, these preliminary findings indicate that the EEG-based ERR-causality test is
capable of separating patients diagnosed with a dementia due to Alzheimer’s disease from HC.
Particularly, the dynamic shift between EO and EC states seems to be lost in AD in the parietal
areas. It is also of interest that the parietal areas showing dysfunction or loss of connectivity in
the DMN on fMRI also show severe abnormalities on our EEG measure. Synchronization during
EO state, measured with the ERR test, is increased in bi-centroparietal regions in people with AD.
Neuronal synchronization between brain structures constitutes a flexible mechanism to coordinate
information flow in the cerebral cortex across several spatiotemporal scales and may be essential
for cognition [63]. Our findings reaffirm the concept that a balanced and temporally precise pattern
of synchronization and desynchronization is pertinent to cognitive function [15]. We show that
patients with AD have very little differences in synchronization between EO versus EC biological
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states, when compared to the results obtained from healthy controls. Furthermore, this ratio strongly
correlates with neuropsychological tests of memory and praxis. In patients with AD, brain networks
appear to be locked at a relatively fixed level of synchronization without the dynamic variations and
responsiveness to external stimuli found in healthy controls. This finding could potentially reflect the
neurophysiological correlate of defective default mode activity modulation in AD. Although causality
between these two findings cannot be inferred, it is reasonable to postulate that the two methods
capture different facets of the same underlying cerebral network dysfunction.
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Appendix A. The Error Reduction Ratio (ERR) Causality tEst
This is a test that we have previously introduced which overcomes most of the disadvantages of
existing methods [30,53,64]. The aim of this approach is to characterize the causal interaction over time
between two signals, denoted by X and Y. At a specific time the following possibilities can occur, signal
X causes Y, Y causes X, X and Y are coincident, there is no interaction, or bidirectional interactions
occur between them. Both X and Y may have been caused by an input u but here u is unknown and
un-measurable. For a complex system, the causality is often time varying and the interactions are often
dynamic and nonlinear.
Initially, construct a candidate term set which is typically constructed by past information of Y,
for example y(t− 1), y(t− 2), ... and past information of X, for example x(t− 1), x(t− 2), ... with a specific
model order d. Apply the adaptive-forward-OLS algorithm which has been derived from the orthogonal
least squares (OLS) algorithm [44] and compute ERR and the penalized error-to-signal ratio PESR) [45]
value for each candidate term. ERR indicates how much of the variance change in the system response is
caused by the considered term, in a percentage form. If the significant terms selected by this algorithm
based on values of ERR include any term from the past information of X, this indicates that signal X leads
Y during the considered time duration (t − h/2, t + h/2) where h denotes the sampling window size -
this was selected at 1000 data points (corresponding to 0.5s) for this work. The ERR-causality from X
to Y at time t, expressed as Fx > y(t) is then defined as 1. If no component from the past information
of X is included in the selected significant terms, this indicates that X has no interaction with Y during
[t − h/2, t + h/2] and Fx > y(t) is defined to be 0. The strength of Fx > y(t) can be estimated using the
summed ERR values of all the selected terms from past information of X, the maximum strength being
1. The time shift of X > Y is defined as the time lag of X in the first term ranked by the values of ERR.
The key advantage of this test is that it can be applied to both linear and nonlinear dynamic systems.
Unlike the well-established Granger-based tests (Granger, 1969) to quantify the causality between two
signals, the ERR-Causality method does not depend on the full knowledge or the estimation of a complete
and unbiased system model. By exploiting an important property of the ERR-Causality test, part of the
orthogonal least squares algorithm, it is shown that the causal flow can be detected even when the model
is incomplete. This is a significant advantage when the underlying system is nonlinear and dynamic and
the measurements may be noisy, because a complete and full model including a nonlinear noise model,
which would normally be required to yield unbiased model estimates, is not required and indeed not even
the full parameter estimates are used in the test. These advantages mean that the test is relatively easy to
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apply and can be used to track fast transitions between causal effects to detect the direction of linear or
nonlinear causal interactions, determine the strength of these interactions, and provide an estimate of the
time lag shift between two EEG signals in this instance. Furthermore, linear and nonlinear interactions
can be separated and analysed independently with this method as there is evidence that the nonlinear
dimension appears to be important in the pathophysiology of AD and cannot be assessed by conventional
qEEG methods [2,25].
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